STREAMEX CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities
STREAMEX CORP. (STEX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$572.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.35M, a 120.22% decline year-over-year.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $780.00K.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$5.80M, a 205.03% decline year-over-year.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $267.00K.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $597.00K, a 4.55% increase from fiscal 2024.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $571.00K, a 58.32% decline from fiscal 2023.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.37M, a 76.55% increase from fiscal 2022.
- STREAMEX CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $776.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$572.00K 10-Q · filed 2026-08-14 | -$6.37M derived: sum of 3 quarters · filed 2026-08-14 | -$6.11M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $780.00K 10-Q · filed 2026-05-14 | -$5.02M derived: sum of 2 quarters · filed 2026-05-14 | -$4.75M derived: sum of 3 quarters · filed 2026-05-14 | $1.93M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$5.54M derived: sum of 2 quarters · filed 2026-03-31 | $1.15M derived: sum of 3 quarters · filed 2026-08-14 | $597.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.95M derived: sum of 2 quarters · filed 2026-08-14 | $6.40M 10-Q · filed 2025-11-14 | $11.92M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $6.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $6.13M 10-Q · filed 2026-08-14 | $5.64M 10-Q · filed 2025-08-15 | $11.66M derived: sum of 3 quarters · filed 2026-08-14 | $9.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$555.00K 10-Q · filed 2026-05-14 | $4.97M derived: sum of 2 quarters · filed 2026-05-14 | $2.79M derived: sum of 3 quarters · filed 2026-05-14 | -$689.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.35M derived: sum of 2 quarters · filed 2026-03-31 | -$134.00K derived: sum of 3 quarters · filed 2026-03-31 | $571.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.66M derived: sum of 2 quarters · filed 2025-11-14 | -$4.95M 10-Q · filed 2025-11-14 | -$4.31M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.78M 10-Q · filed 2024-08-14 | -$2.13M derived: sum of 3 quarters · filed 2025-05-19 | -$1.56M derived: sum of 4 quarters · filed 2025-05-19 | |
| 2024-03-31 | $705.00K 10-Q · filed 2025-05-19 | $1.35M derived: sum of 2 quarters · filed 2025-05-19 | $1.92M derived: sum of 3 quarters · filed 2025-05-19 | $2.43M derived: sum of 4 quarters · filed 2025-05-19 | |
| 2023-12-31 | $646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.21M derived: sum of 2 quarters · filed 2025-04-15 | $1.73M derived: sum of 3 quarters · filed 2025-04-15 | $1.37M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.08M derived: sum of 2 quarters · filed 2024-11-14 | $724.00K 10-Q · filed 2024-11-14 | $1.59M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $514.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $159.00K 10-Q · filed 2024-08-14 | $1.02M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$355.00K 10-Q · filed 2024-05-20 | $508.00K derived: sum of 2 quarters · filed 2024-05-20 | |||
| 2022-12-31 | $863.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $776.00K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$87.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |